%0 Journal Article
%T Management of Bladder Tumors: What Results in 10 Years of Practice at the University Clinic of Urology-Andrology of the CNHU-HKM of Cotonou?
%A Dodji Magloire Ines Yevi
%A Akim Kogui Douro
%A Jean Sossa
%A Marlene Gankpe
%A Fred Hodonou
%A Michel Michael Agounkpe
%A Gilles Natchagande
%A Khadidjatou Ouake
%A Josu&#233
%A Avakoudjo
%J Open Journal of Urology
%P 173-197
%@ 2160-5629
%D 2025
%I Scientific Research Publishing
%R 10.4236/oju.2025.156020
%X <b>Introduction</b>: Bladder tumors are the 2nd largest urological cancer with an increasing incidence of about 1% per year. The aim of our study was to determine the prevalence of bladder tumors at the University Clinic of Urology-Andrology of the National University Hospital Center Hubert Koutoukou Maga of Cotonou, to describe the diagnostic aspects, and to evaluate the therapeutic modalities used. <b>Patients and Methods: </b>This was a descriptive, retrospective, and analytical study with a cross-sectional data collection, listing 68 cases of bladder tumors over a 10-year period from January 2013 to December 2022. <b>Results</b>: Men predominated (67.65%) with a sex ratio of 2.09. The mean age of patients was 57.22 &#177; 13.79 years, with extremes of 16 years and 89 years. The age group of 60 to 69 years was the most represented and made up 29.41% of patients. Hematuria was the main reason for consultation (45.59%). History was dominated by smoking (17.65%) and urinary schistosomiasis (14.71%). One of the patients was exposed to occupational carcinogens. The clinical picture was dominated by conjunctival pallor (47.1%) and deterioration in general condition (42.65%). Para clinically, pelvic ultrasound was performed by 88.24% of patients with a sensitivity of 77.84%. Cystoscopy performed by 36 patients (52.94%) confirmed the lesion in 97.22% of cases. The tumors were budding (88.57%), sessile (97.14%) and multifocal (20%). The non-muscle infiltrating bladder tumor accounted for 51.47% of cases. Histopathological examination was performed in 22 patients (32.35%) with a predominance of urothelial carcinoma. Forty patients (58.82%) had received treatment, including 38 surgeries and 2 endovesical instillations. A total of 61.76% of patients were lost to follow-up, 8.82% had progression-free follow-up, 2.94% had tumor regrowth, and 26.47% died. <b>Conclusion:</b> Bladder tumours remain a public health problem. Diagnosis is clinical and, above all, paraclinical. The best treatment is to prevent risk factors.
%K Tumors
%K Bladder
%K Hematuria
%K Schistosomiasis
%K Benin
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=143263